ARTICLE | Clinical News
Ad5: Phase II data
April 4, 2016 7:00 AM UTC
Top-line combined data from the 2 highest dose groups of RT-100 in a double-blind, U.S. Phase II trial in 56 symptomatic heart failure patients with an ejection fraction of <=40% showed that intracoro...